Pluristem Therapeutics Inc. 8-K Summary
Business Context and Reporting Period
This Form 8-K reports the results of the annual meeting of stockholders held by Pluristem Therapeutics Inc. on May 17, 2011. The report was filed on May 19, 2011. The company is incorporated in Nevada with principal executive offices in Haifa, Israel.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results.
Material Changes
The primary event reported is the election of directors. All eight nominees were elected to the Board of Directors. There were no broker non-votes recorded for any nominee.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It is a procedural report of voting outcomes.
Key Facts for Investors
- Event: Annual Meeting of Stockholders held on May 17, 2011.
- Outcome: All 8 director nominees were successfully elected.
- Voting Details:
- Shai Pines: Received the highest "For" votes (13,884,573) and lowest "Against" votes (16,999).
- Mark Germain: Received the lowest "For" votes (11,933,374) and highest "Against" votes (1,904,991).
- Zami Aberman: Received 12,153,803 "For" votes and 1,934,237 "Against" votes.
- Abstentions: Abstention votes ranged from 83,091 to 332,766 across nominees.